Novartis Investigative Site

Zhenjiang 310009

0 studies enrolling now · 1 studies all time

What they study most

Early Breast Cancer

Studies at this site

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling